Proposition 65 titanium dioxide lawsuits have been halted by a ruling in California in a First Amendment case, which could bode favorably for other scientific challenges to mandated warning labels.

Cosmetic Ingredient Review’s independent expert panel needs more data to assess the safety of prostaglandin analogs, but ultimately may pass review back to the US Food and Drug Administration due to concerns that the substances impact the structure and function of the body and thus are unapproved drugs with potentially serious side effects.

Amid organizational and leadership changes and numerous competing high priorities, the FDA’s planned Notice of Proposed Rulemaking to ban formaldehyde-containing hair-straightening products has been pushed from April to July 2024. An agency spokesperson provided an update on related activities, which are being closely watched by NGOs, state-level policymakers, and industry stakeholders.

Aimed at curbing so-called "Sephora kids" purchases of anti-aging cosmetic products, a California bill would prohibit sale of skin-care products or cosmetics containing retinol or AHAs to consumers under age 13.

AdvaMed is hopeful that legislation at the US federal and state levels will temper third-party litigation funding, which is wreaking havoc on the judiciary system and fostering mistrust of medical devices, it says.

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.